Kevin Appelbaum's most recent trade in Better Therapeutics Inc was a trade of 235,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 31, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Better Therapeutics Inc | Kevin Appelbaum | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
| Better Therapeutics Inc | Kevin Appelbaum | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.97 per share. | 31 Mar 2022 | 2,500 | 6,250 | - | 2.0 | 4,921 | Common Stock |
| Better Therapeutics Inc | Kevin Appelbaum | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.60 per share. | 20 Dec 2021 | 1,000 | 3,750 | - | 4.6 | 4,600 | Common Stock |
| Better Therapeutics Inc | Kevin Appelbaum | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.98 per share. | 10 Dec 2021 | 1,000 | 2,000 | - | 6.0 | 5,975 | Common Stock |
| Better Therapeutics Inc | Kevin Appelbaum | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.43 per share. | 02 Dec 2021 | 500 | 1,000 | - | 6.4 | 3,213 | Common Stock |
| Better Therapeutics Inc | Kevin Appelbaum | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.84 per share. | 02 Dec 2021 | 500 | 500 | - | 6.8 | 3,420 | Common Stock |